Dive into a collection of past posts and rediscover timeless content.
Revenue more than doubled year over year, and earnings growth hit triple digits. See if this investment bank’s surge in deal flow makes it worth adding to your portfolio now.
Hormuz supply disruptions hit this chemicals giant in Q1 and pushed it 57% below its cash flow value. Management is guiding a Q2 snapback. The recovery print is August 5.
A Palo Alto cybersecurity partnership launched, a board member bought shares personally, and Q2 earnings land on August 6. Find out if Europe’s largest telecom deserves a position now.
A defensive grocery name just closed a $1.25 billion regional acquisition while private-label mix keeps expanding margins. Q2 prints September 4. Read this now.
An engineering company’s CFO bought stock personally, two defense contracts landed, and the January 2027 spinoff just got a leadership team. See if the setup justifies a position.
The most dominant US sports betting brand trades well below its cash flow fair value with the NFL season two months out and US EBITDA finally turning positive. Here’s the setup.
The music rights company beat Q2 EPS by 63%, expanded margins by 230bps, and still trades at a discount to Universal Music. See if Q3 closes the gap.
From undervalued turnarounds and activist opportunities to fast movers and market headlines, here's what deserves your attention right now.
A diagnostics name slashed guidance, but a top asset manager kept buying as the stock fell, and a strategic review may be underway. Here’s the full breakdown.